CONARIS has been founded in 1999 and is a spin-off from the University Hospital of Schleswig-Holstein, Germany. The company is located in the Innovation and Technology Center of Kiel (KITZ) and is engaged in the preclinical and early clinical development of  innovative drugs with a special focus on inflammatory indications.